Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma

Journal of Vascular and Interventional Radiology

Volumn 23, Issue 12, 2012, Pages 1613-1621

  Narayanan, Govindarajan ^a   Hosein, Peter J ^a   Arora, Geetika ^a   Barbery, Katuzka J ^a   Froud, Tatiana ^a   Livingstone, Alan S ^a   Franceschi, Dido ^a   Rocha Lima, Caio M ^a   Yrizarry, Jose ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

EFS; event free survival; IRE; irreversible electroporation; LAPC; locally advanced pancreatic cancer; OS; overall survival; radiofrequency; RF

Indexed keywords

ABDOMINAL PAIN; ABLATION THERAPY; ADULT; ADVANCED CANCER; AGED; ANESTHESIA COMPLICATION; ARTICLE; AUTOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; ELECTROPORATION; EVENT FREE SURVIVAL; FEMALE; GENERAL ANESTHESIA; HEPATIC ARTERY; HUMAN; IRREVERSIBLE ELECTROPORATION; MALE; METASTASIS; NAUSEA; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREATITIS; PATIENT SAFETY; PRIORITY JOURNAL; SPONTANEOUS PNEUMOTHORAX; TREATMENT RESPONSE; TUMOR VOLUME; VASCULARIZATION;

ADENOCARCINOMA; AGED; CATHETER ABLATION; ELECTROPORATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATECTOMY; PANCREATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 84870042094     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2012.09.012     Document Type: Article

References (29)

1. American Cancer Society Cancer Facts & Figures 2011 2011 American Cancer Society Atlanta
2. M.P. Callery, K.J. Chang, E.K. Fishman, M.S. Talamonti, L. William Traverso, and D.C. Linehan Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement Ann Surg Oncol 16 2009 1727 1733
3. S. Gillen, T. Schuster, C. Meyer Zum Büschenfelde, H. Friess, and J. Kleeff Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages PLoS Med 7 2010 e1000267
4. M.J. Moore, D. Goldstein, and J. Hamm National Cancer Institute of Canada Clinical Trials Group. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 25 2007 1960 1966
5. T. Conroy, F. Desseigne, and M. Ychou Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer N Engl J Med 364 2011 1817 1825
6. P.J. Loehrer Sr, Y. Feng, and H. Cardenes Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group Trial J Clin Oncol 29 2011 4105 4112
7. F. Huguet, T. André, and P. Hammel Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies J Clin Oncol 25 2007 326 331
8. R. Pezzilli, C. Serra, and C. Ricci Radiofrequency ablation for advanced ductal pancreatic carcinoma: is this approach beneficial for our patients? A systematic review Pancreas 40 2011 163 165
9. R. Girelli, I. Frigerio, and R. Salvia Feasibility and safety of radiofrequency ablation for locally advanced pancreatic cancer Br J Surg 97 2010 220 225
10. P. Hadjicostas, N. Malakounides, C. Varianos, E. Kitiris, F. Lerni, and P. Symeonides Radiofrequency ablation in pancreatic cancer HPB (Oxford) 8 2006 61 64
11. M. D'Onofrio, E. Barbi, and R. Girelli Radiofrequency ablation of locally advanced pancreatic adenocarcinoma: an overview World J Gastroenterol 16 2010 3478 3483
12. N.J. Lygidakis, S.K. Sharma, and P. Papastratis Microwave ablation in locally advanced pancreatic carcinoma - a new look Hepatogastroenterology 54 2007 1305 1310
13. L. Thanos, L.S. Poulou, L. Mailli, M. Pomoni, and D.A. Kelekis Image-guided radiofrequency ablation of a pancreatic tumor with a new triple spiral shaped electrode Cardiovasc Intervent Radiol 33 2010 215 218
14. Y. Wu, Z. Tang, and H. Fang High operative risk of cool-tip radiofrequency ablation for unresectable pancreatic head cancer J Surg Oncol 94 2006 392 395
15. J. Li, X. Chen, and H. Yang Tumour cryoablation combined with palliative bypass surgery in the treatment of unresectable pancreatic cancer: a retrospective study of 142 patients Postgrad Med J 87 2011 89 95
16. R. Davalos, L.M. Mir, and B. Rubinsky Tissue ablation with irreversible electroporation Ann Biomed Eng 33 2005 223 231
17. E. Maor, A. Ivorra, J. Leor, and B. Rubinsky The effect of irreversible electroporation on blood vessels Technol Cancer Res Treat 6 2007 307 312
18. J.T. Au, J. Wong, and A. Mittra Irreversible electroporation is a surgical ablation technique that enhances gene transfer Surgery 150 2011 474 479
19. A. José, L. Sobrevals, A. Ivorra, and C. Fillat Irreversible electroporation shows efficacy against pancreatic carcinoma without systemic toxicity in mouse models Cancer Lett 317 2012 16 23
20. K.P. Charpentier, F. Wolf, L. Noble, B. Winn, M. Resnick, and D.E. Dupuy Irreversible electroporation of the pancreas in swine: a pilot study HPB (Oxford) 12 2010 348 351
21. M. Bower, L. Sherwood, Y. Li, and R. Martin Irreversible electroporation of the pancreas: definitive local therapy without systemic effects J Surg Oncol 104 2011 22 28
22. E.W. Lee, C.T. Loh, and S.T. Kee Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation Technol Cancer Res Treat 6 2007 287 293
23. C. Bertacchini, P.M. Margotti, E. Bergamini, A. Lodi, M. Ronchetti, and R. Cadossi Design of an irreversible electroporation system for clinical use Technol Cancer Res Treat 6 2007 313 320
24. K.R. Thomson, W. Cheung, and S.J. Ellis Investigation of the safety of irreversible electroporation in humans J Vasc Interv Radiol 22 2011 611 621
25. M. Pech, A. Janitzky, and J.J. Wendler Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study Cardiovasc Intervent Radiol 34 2011 132 138
26. S. Bagla, and D. Papadouris Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: a case report J Vasc Interv Radiol 23 2012 142 145
27. R.C. Martin II, K. McFarland, S. Ellis, and V. Velanovich Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma J Am Coll Surg 215 2012 361 369
28. K.P. Olive, M.A. Jacobetz, and C.J. Davidson Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer Science 324 2009 1457 1461
29. C.M. Ellis, S. Shenoy, A. Litwin, S. Soehnlein, and J.F. Gibbs Effective endovascular stenting of malignant portal vein obstruction in pancreatic cancer HPB Surg 2009 2009 426436